Elon Musk Breaking Boundaries: The Inspiring Journey of Neuralink’s First Human Patient towards Self-IndependenceOctober 1, 20250 Benchmark has reaffirmed its “Buy” rating and $475 price target on Tesla stock (NASDAQ: TSLA) as the company gears up…
Elon Musk Global Access Available for Neuralink’s Patient RegistryApril 4, 20250 Tesla Germany experienced a decline in sales in Q1 2025, selling 4,935 units, which was a significant drop compared to…